Clinical trial
Vinblastine and Methotrexate in Treating Children With Desmoid Tumors
NCT00003019 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003019 |
|---|---|
| Title | Vinblastine and Methotrexate in Treating Children With Desmoid Tumors |
| Official title | Vinblastine and Methotrexate in Children With Desmoid Tumor (Aggressive Fibromatosis) Which is Recurrent or Not Amenable to Surgical Resection or Irradiation - A Pediatric Oncology Group Phase II Study |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH Children's Cancer Group |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Desmoid Tumor |
| Intervention type | Drug |
| Interventions | methotrexate, vinblastine sulfate |
| Enrollment | 28 |
| Start date | Aug 1, 1997 |
| Primary completion | Jul 1, 2003 |
| Completion | Sep 1, 2006 |
| First posted | Apr 30, 2004 |
| Last update posted | Jul 25, 2014 |
| Countries | Australia, Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: